Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K, filed on August 2, 2011, reports the second-quarter results for Fresenius Medical Care AG & Co. KGaA for the period ending June 30, 2011. The filing serves to distribute an Investor News release (Exhibit 99.1) containing the company's financial performance for the quarter.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references an attached Investor News release that contains these figures, including non-GAAP measures such as EBITDA and free cash flow, but the specific data points are not present in the provided text.
Material Changes
The filing text does not detail specific material changes or year-over-year comparisons. It notes that the attached Investor News includes reconciliations of non-GAAP measures to GAAP measures to ensure consistency and comparability with prior periods.
Guidance, Outlook, and Risks
The filing states that the non-GAAP measures are provided to enhance understanding of the company's current performance and future prospects. However, the text does not contain specific guidance, management commentary on risks, contingencies, or unusual items. It explicitly warns that non-GAAP measures should not be used as a substitute for GAAP financial measures.
Investor Verification Checklist
- Verify the specific revenue, EBITDA, and free cash flow figures in the attached Exhibit 99.1 (Investor News).
- Review the reconciliation tables in the Investor News to understand the adjustments between GAAP and non-GAAP measures.
- Confirm the full text of management commentary and risk factors, which are referenced but not included in this summary text.
- Check the Cash Flow Statement referenced in the filing for detailed liquidity data.